An Overview of Radiation-Induced Nausea and Vomiting

详细信息    查看全文

• 作者：Leigha Rowbottom ; MD(C) ; Rachel McDonald ; MD(C) ; Angela Turner ; MRT (T) ; Edward Chow ; MBBS ; Carlo DeAngelis ; PharmD ; ^{carlo.deangelis@sunnybrook.ca" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Radiotherapy ; RINV ; nausea ; vomiting ; emetic risk ; antiemetic
• 刊名：Journal of Medical Imaging and Radiation Sciences
• 出版年：2016
• 出版时间：September 2016
• 年：2016
• 卷：47
• 期：3_supp_S
• 页码：S29-S38
• 全文大小：266 K

文摘

Radiation-induced nausea and vomiting (RINV) is common occurrence in cancer patients treated with radiotherapy. When radiation is prescribed to certain sites, it can lead to retching, vomiting, and nausea that can lead to impairments on quality of life and even effect adherence to treatment regimes. The present study reports select literature examining RINV phenomena and reviews mechanisms of RINV as well as current management strategies.

Methods

A literature search was conducted on PubMed using search strategies such as “radiation-induced nausea vomiting,” “RINV,” and “radiation and antiemetics.” The search was limited to articles published from January 2000 to April 2016 and those that involved humans and were published in English. Information regarding emetic risk of each treatment and management strategies used were extracted from each article.

Results

A total of 25 articles were included in this select review. The current evidence regarding the standard antiemetics for RIINV are discussed, as well as upcoming therapies and future potential endeavors.

Conclusions

Cancer patients treated with emetogenic radiotherapy are at risk of experiencing RINV. RINV has the potential to impact patient quality of life and treatment delivery and optimal prophylactic strategies should be implemented, particularly in radiation naïve patients. More awareness on these topics is warranted, so that standard antiemetic regimens can be used in both the prophylactic and rescue settings.